The use of exogenous phosphocreatine in surgical correction of valvular heart defects under cardiopulmonary bypass: a randomized, double-blind, placebo-controlled pilot study
Vladimir Boboshko(Meshalkin National Medical Research Center), A. М. Chernyavskiy(Physical Sciences (United States)), A.S. Zalesov, V. A. Nepomnyashchikh, P. P. Perovskiy, В Н Ломиворотов, V. Ya. Martynenkov, А. Н. Шилова
Cited by 0
Related Papers
Levosimendan for Hemodynamic Support after Cardiac Surgery
|New England Journal of Medicine|2017|299
Prognostic value of nutritional screening tools for patients scheduled for cardiac surgery
|Interactive Cardiovascular and Thoracic Surgery|2013|101
Evaluation of nutritional screening tools for patients scheduled for cardiac surgery
|Nutrition|2012|99
Levosimendan Versus an Intra-Aortic Balloon Pump in High-Risk Cardiac Patients
|Journal of Cardiothoracic and Vascular Anesthesia|2011|60